Anika Therapeutics, Inc. (ANIK)
14.14
+0.03
(+0.21%)
USD |
NASDAQ |
Mar 19, 14:58
Anika Therapeutics Profit Margin (Quarterly) : 5.88% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 60.47% |
| Lantheus Holdings, Inc. | 13.30% |
| TELA Bio, Inc. | -41.58% |
| Plus Therapeutics, Inc. | -417.9% |
| BioStem Technologies, Inc. | 7.27% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.74% |
| Return on Assets | -5.06% |
| Return on Invested Capital | -5.75% |
| Gross Profit Margin (Quarterly) | 62.65% |
| Operating Margin (Quarterly) | 2.11% |
| Return on Net Operating Assets | -8.42% |